A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

7.4K views

⸱

DOI:

10.3791/55356

⸱

March 30th, 2017

In This Article

Summary

During development of drugs for pulmonary delivery, it is necessary to evaluate pharmacokinetics and efficacy in an animal model. We present a method to build a disposable aerosol dispersion system from of-the-shelf components that can be used to administer intrapulmonary dry powder aerosol to rodents.

Abstract

Development of new therapeutic products requires efficacy testing in an animal model. The pulmonary route of administration can be utilized to deliver drugs locally and systemically. Evaluation of dry powder aerosols necessitates an efficient dispersion mechanism to maintain high concentrations in an exposure chamber or for direct endotracheal administration. While solutions exist to expose animals by passive inhalation to dry powder aerosols, most require masses of powder in large excess of the dose delivered. This precludes conducting early feasibility studies as insufficient drug is available at the research or early development stage to support the dose delivery requirements for conventional aerosol delivery systems. When designing an aerosol drug product, aerodynamic performance can relate directly to delivery efficiency and efficacy. Dispersion of powder into an aerosol requires energy input sufficient to overcome interparticulate forces, and particle engineering approaches can substantially improve aerosol performance. We have developed a dispersion system (dosator) which can aerosolize engineered dry powder aerosols efficiently for the purpose of direct pulmonary insufflation, dispersion into an exposure system or generation for analytical purposes.

Introduction

Development of new therapeutic products requires efficacy testing in an animal model. The pulmonary route of administration can be utilized to deliver drugs locally and systemically 1. Evaluation of dry powder aerosols necessitates an efficient dispersion mechanism to maintain high concentrations in an exposure chamber or for direct endotracheal administration. While solutions exist to expose animals by passive inhalation to dry powder aerosols, most require masses of powder in large excess of the dose delivered 2.

This precludes conducting early feasibility studies as insufficient drug is ava....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparation of Components of the Dosators

  1. Perforate the bottom of a 0.5 mL polypropylene microcentrifuge tube by drilling or by simply grinding or cutting off the bottom with a grinding wheel or a sharp pair of scissors. Ensure that the hole is in the center and is no more than 2 mm in diameter and no less than 1 mm in diameter (Figure 1).
  2. Perforate the top of the microcentrifuge tube. Using a #22 drill bit (approximately 4 mm in diameter), drill a hole in the center of the cap. This results in a hole that will fit a slip-tip syringe (Figure 1).
  3. Prepare the fine screens to be inserted into the microc....

Access restricted. Please log in or start a trial to view this content.

Results

For easily dispersible powders such as those spray-dried with the intent for pulmonary delivery 5,8,9, the dosators deliver a bolus dose out of the device. There are many applications for the dosators, including in vitro particle characterization, direct intrapulmonary administration in live animals, and aerosol generation for passive inhalation systems.

Access restricted. Please log in or start a trial to view this content.

Discussion

The dispersion from the dosators was suitable for animals to receive a therapeutic dose via passive nose-only respiration, indicating a large proportion of aerosol dispersed to primary particle size. These dosators can be used for endotracheal administration, in vitro evaluation of powder performance, and general purpose dry powder aerosol dispersion for analytical or efficacious experiments. If used for intrapulmonary delivery, it is important to use an appropriate volume of air for the species chosen, as over-.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Portions of the pharmacokinetic data was presented at Respiratory Drug Delivery 2014 in Fajardo, Puerto Rico and dosator depictions and additional pharmacokinetic data were presented at the annual meeting of the American Association of Pharmaceutical Scientists 2015 in Orlando, Florida.

Acknowledgements

Authors would like to kindly thank the National Institute for Allergy and Infectious Disease for the funding to conduct this research.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.5 mL microcentrifuge tubeVWR89000-026
High-Volume Particle-Filtering Stainless Steel Wire Cloth, Woven, 304 Stainless Steel, 60 x 60 Mesh, .0045" Wire DiameterMcMaster Carr9230T44
Stainless Steel Dispensing Needle, Straight, 18 Gauge, 1" LongMcMaster Carr75165A676Any luer-fit needle will suffice
Cotton ballsMcMaster Carr54845T16
Parafilm M® Laboratory FilmVWR100229-550
Black-Oxide High-Speed Steel Jobbers' Drill Bit, Wire Gauge 22, 3-1/8" Overall Length, 1.8" Drill Depth, 135Deg PointMcMaster Carr2901A195

References

  1. Young, E. F., et al. Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis. Pharmaceutical Research. , 1-11 (2016).
  2. Hinds, W. C. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. , Wiley. (2012).
  3. Islam, N., Gladki,....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Dry Powder AerosolsAerosol Dispersion SystemSmall Animal ModelsExposure ChamberEndotracheal AdministrationDrug DeliveryAerosol DevelopmentParticle Engineering